‘Omics’-driven discoveries in prevention and treatment of type 2 diabetes

Panels of multiple biomarkers reflecting several pre-diabetic pathologies have been developed. Their specificity and potentials for future risk stratification are discussed. The review also explores the perspectives of selected examples within applied genomics and metagenomics for improving patient care by facilitating interventions tailored to specific subpopulations (European Journal of Clinical Investigation)